Skip to content

Clinical trials

Phase 3 Heart Failure trials in Hungary

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Failure Phase: Phase 3 Country / region: Hungary Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20022
20031
20051
20063
20091
20122
20131
20143
20151
20177
20182
20192
20202
20231
20245
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting11
Terminated6
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
AstraZeneca5
Boehringer Ingelheim5
Bayer3
Amgen2
Colorado Prevention Center2
Janssen Research & Development, LLC2
Lexicon Pharmaceuticals2
Sanofi2
American Regent, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure41
Cardiovascular Diseases4
Stroke3
Coronary Artery Disease2
Diabetes Mellitus, Type 22
Heart Diseases2
Hypertension2
Myocardial Infarction2
Renal Insufficiency, Chronic2
Ventricular Dysfunction, Left2

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.